| 378- | AgNPs, | Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer |
| - | ex-vivo, | BC, | 4T1 |
| 379- | AgNPs, | Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo |
| - | in-vivo, | Lung, | H1299 |
| 380- | AgNPs, | QC, | CA, | Chit, | Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities |
| - | in-vitro, | MG, | U118MG |
| 381- | AgNPs, | Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression |
| - | in-vitro, | Bladder, | 5637 |
| 382- | AgNPs, | Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways |
| - | in-vitro, | BC, | MDA-MB-231 |
| 383- | AgNPs, | In vitro and in vivo evaluation of anti-tumorigenesis potential of nano silver for gastric cancer cells |
| - | in-vitro, | GC, | MKN45 |
| 385- | AgNPs, | Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment |
| - | in-vitro, | Hepat, | HepG2 | - | in-vitro, | Hepat, | WI38 |
| 386- | AgNPs, | Tam, | Synergistic anticancer effects and reduced genotoxicity of silver nanoparticles and tamoxifen in breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 387- | AgNPs, | Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells |
| - | in-vitro, | Colon, | HT-29 |
| 388- | AgNPs, | Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells |
| - | in-vitro, | BC, | MCF7 |
| 390- | AgNPs, | Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | BC, | NA |
| 384- | AgNPs, | Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy |
| - | in-vitro, | Testi, | F9 |
| 2288- | AgNPs, | Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model |
| - | Review, | Var, | NA |
| 2287- | AgNPs, | Silver nanoparticles induce endothelial cytotoxicity through ROS-mediated mitochondria-lysosome damage and autophagy perturbation: The protective role of N-acetylcysteine |
| - | in-vitro, | Nor, | HUVECs |
| 2286- | AgNPs, | Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size |
| - | in-vitro, | Nor, | 3T3 |
| 2837- | AgNPs, | Trojan-Horse Mechanism in the Cellular Uptake of Silver Nanoparticles Verified by Direct Intra- and Extracellular Silver Speciation Analysis |
| - | in-vitro, | NA, | NA |
| 2836- | AgNPs, | Gluc, | Glucose capped silver nanoparticles induce cell cycle arrest in HeLa cells |
| - | in-vitro, | Cerv, | HeLa |
| 2835- | AgNPs, | Gluc, | Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake |
| - | in-vitro, | Liver, | HepG2 |
| 2834- | AgNPs, | Gluc, | Electrochemical oxidation of glucose on silver nanoparticle-modified composite electrodes |
| - | Study, | NA, | NA |
| 2208- | AgNPs, | Sepsis diagnosis and treatment using nanomaterials |
| - | Review, | NA, | NA |
| 2207- | AgNPs, | TQ, | Protective effects of Nigella sativa L. seeds aqueous extract-based silver nanoparticles on sepsis-induced damages in rats |
| - | in-vivo, | Nor, | NA |
| 2206- | AgNPs, | RES, | ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION |
| - | in-vivo, | Nor, | NA |
| 2205- | AgNPs, | Potential protective efficacy of biogenic silver nanoparticles synthesised from earthworm extract in a septic mice model |
| - | in-vivo, | Nor, | NA |
| 2538- | AgNPs, | SDT, | Z, | Dual-functional silver nanoparticle-enhanced ZnO nanorods for improved reactive oxygen species generation and cancer treatment |
| - | Study, | Var, | NA | - | vitro+vivo, | NA, | NA |
| 2539- | AgNPs, | SDT, | Combined effect of silver nanoparticles and therapeutical ultrasound on ovarian carcinoma cells A2780 |
| - | in-vitro, | Melanoma, | A2780S |
| 7426- | AgNPs, | CS, | Silver Nanoparticles Formulation of Flower Head's Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Lung, | A549 |
| 7292- | Aidi, | Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and meta-analyses |
| - | Review, | Var, | NA |
| 5340- | Ajoene, | Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB |
| - | in-vitro, | AML, | NA |
| 5341- | Ajoene, | Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy |
| - | Review, | AML, | NA |
| 5342- | Ajoene, | The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis |
| - | in-vivo, | BCC, | NA |
| 5343- | Ajoene, | The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | BC, | MDA-MB-231 |
| 5344- | Ajoene, | Ajoene, a Stable Garlic By-Product, Has an Antioxidant Effect through Nrf2-Mediated Glutamate-Cysteine Ligase Induction in HepG2 Cells and Primary Hepatocytes |
| - | in-vitro, | Nor, | HepG2 |
| 252- | Ajoene, | Ajoene, a Compound of Garlic, Induces Apoptosis in Human Promyeloleukemic Cells, Accompanied by Generation of Reactive Oxygen Species and Activation of Nuclear Factor κB |
| - | in-vitro, | AML, | HL-60 |
| 540- | Akk, | Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy |
| - | Analysis, | NA, | NA |
| 541- | Akk, | Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut-Liver-Brain Axes? |
| - | Review, | NA, | NA |
| 542- | Akk, | immuno, | Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors |
| 543- | Akk, | Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer |
| 4- | Akk, | The Emerging Biotherapeutic Agent: Akkermansia |
| - | Review, | Var, | NA |
| 5350- | Akk, | immuno, | Enhancing Immune Response in Immunotherapy-Resistant Melanoma Through Fecal Microbiota Transplantation: A Systematic Review |
| 5351- | Akk, | Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut |
| - | Human, | Diabetic, | NA |
| - | Case Report, | Melanoma, | NA |
| 5348- | Akk, | immuno, | Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency |
| - | Human, | Var, | NA |
| 5347- | Akk, | immuno, | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer |
| - | Human, | NSCLC, | NA |
| 5346- | Akk, | immuno, | Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors |
| - | in-vivo, | Var, | NA |
| 5353- | AL, | Aged Garlic Extract May Be Safe for Patients on Warfarin Therapy |
| - | Human, | Nor, | NA |
| 5352- | AL, | Anticancer potential of allicin: A review |
| - | Review, | Var, | NA |
| 5356- | AL, | Therapeutic role of allicin in gastrointestinal cancers: mechanisms and safety aspects |
| - | Review, | GC, | NA |
| 5355- | AL, | Mini-review: The health benefits and applications of allicin |
| - | Review, | Var, | NA |
| 5354- | AL, | Therapeutic Potential of Allicin-Rich Garlic Preparations: Emphasis on Clinical Evidence toward Upcoming Drugs Formulation |
| - | Review, | Var, | NA |
| 1916- | AL, | Allicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid